|
|
|
26.03.26 - 14:48
|
Trading by management and close relations of management (GlobeNewswire EN)
|
|
|
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the “Market Abuse Regulation”) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novonesis reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B....
|
|
|
|
|
23.03.26 - 13:57
|
Trading by management and close relations of management (GlobeNewswire EN)
|
|
|
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the “Market Abuse Regulation”) and commission delegated regulation (EU) 1052/2016of 8 March 2016, Novonesis reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B....
|
|
|
22.03.26 - 21:42
|
XETR: DIVIDEND/INTEREST INFORMATION - 24.03.2026 - DK0060336014 (XETRA)
|
|
|
Das Instrument NZM2 DK0060336014 NOVONESIS A/S NAM. B DK 2 EQUITY wird cum Dividende/Zinsen gehandelt am 23.03.2026 und ex Dividende/Zinsen am 24.03.2026
The instrument NZM2 DK0060336014 NOVONESIS A/S NAM. B DK 2 EQUITY has its pre-dividend/interest day on 23.03.2026 and its ex-dividend/interest day on 24.03.2026...
|
|
|
|
|
13.03.26 - 10:00
|
Novonesis issues EUR 1.7 billion senior unsecured notes (GlobeNewswire EN)
|
|
|
On March 12, 2026, Novonesis, through Novozymes A/S, successfully priced and closed an aggregate principal amount of EUR 1.7 billion senior unsecured notes (the "Notes"). The issuance was completed under the newly established EUR 4 billion Euro Medium Term Note (EMTN) Programme, dated March 10, 2026....
|
|
|
11.03.26 - 13:42
|
Trading by management and close relations of management (GlobeNewswire EN)
|
|
|
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the “Market Abuse Regulation”) and commission delegated regulation (EU) 1052/2016of 8 March 2016, Novonesis reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B....
|
|
|
09.03.26 - 22:36
|
Novonesis named a Great Employer to Work For in North Carolina (GlobeNewswire EN)
|
|
|
Franklinton, North Carolina, March 09, 2026 (GLOBE NEWSWIRE) -- Novonesis, a global leader in biosolutions, has been named a 2026 Great Employer to Work for in North Carolina by Best Companies Group (BCG), marking the company's first time earning this prestigious recognition. BCG is a trusted leader in workplace culture research and recognition, distinguishing top companies around the United States for more than 20 years. The honor is based entirely on confidential employee feedback and a comprehensive evaluation of workplace practices, culture, and leadership. ...
|
|
|
27.02.26 - 10:27
|
Trading by management and close relations of management (GlobeNewswire EN)
|
|
|
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the “Market Abuse Regulation”) and commission delegated regulation (EU) 1052/2016of 8 March 2016, Novonesis reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B....
|
|
|
26.02.26 - 17:06
|
Trading by management and close relations of management (GlobeNewswire EN)
|
|
|
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the “Market Abuse Regulation”) and commission delegated regulation (EU) 1052/2016of 8 March 2016, Novonesis reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B....
|
|
|
26.02.26 - 12:03
|
Invitation to the 2026 Annual General Meeting (GlobeNewswire EN)
|
|
|
The Annual General Meeting of Novonesis (Novozymes A/S) will be held on Monday March 23, 2026 at 4:00 pm CET at Gammel Venlighedsvej 14, DK-2970 Hoersholm, Denmark. There will also be access to the meeting from the entrance at Boege Alle 10-12, DK-2970 Hoersholm, Denmark....
|
|
|
26.02.26 - 11:27
|
Trading by management and close relations of management (GlobeNewswire EN)
|
|
|
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the “Market Abuse Regulation”) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novonesis reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B....
|
|
|
26.02.26 - 06:12
|
Novozymes Reports Climb In Q4 Bottom Line (AFX)
|
|
|
BRUSSELS (dpa-AFX) - Novozymes (NVZMF.PK) reported earnings for its fourth quarter that Increases, from the same period last yearThe company's earnings came in at EUR122.8 million, or EUR1.25 per ......
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
